Regarding insider purchases and shares outstanding here in copied from a post by greg copied from the 1997 annual report...1997 Trinity Bio Annual Report, page 14:
Insider holdings as of 12/97 (vs 12/96):
Ronan O'Caoimh: from 135,000 to 905,000 shares ; 479,000 options avail
Brendan Farrell: from 45,000 to 430,000 shares ; 436,875 options avail
Jonathan O'Connell: from 60,000 to 460,000 shares ; 277,000 options
avail
Jim Walsh: from 0 to 500,000 shares ; 380,000 options avail
Denis Burger: from 195,000 to 391,000 shares ; 239,000 options avail
I find it rather a coincidence that the figures listed as shares owned at the end of the last year match exactly the amount that would be owned if you add the options shares from the March 19th 1998 press release to shares previously owned. That means a number of things. First the "purchase" they so boldly mentioned in a press release on March 19th this year, actually were options exercised sometime during 1997. Why the delay? Rather misleading, particularly given the run to close to $3 on this "new" information. Second, these additional shares are part of the year end share count and thus not all of the growth in shares year to date 1998 can be attributed to these exercises as they took place sometime last year, and at an undisclosed date and price.
Follow the insiders? Not likely when they are obviously not willing to disclose information in a timely way, never mind half the story in a less than forthright manner. |
